168 related articles for article (PubMed ID: 32980536)
1. Tyrosine-phosphorylation and activation of glucosylceramide synthase by v-Src: Its role in survival of HeLa cells against ceramide.
Honda T; Motoyoshi K; Kasahara J; Yamagata K; Takahashi H; Nakamura H; Murayama T
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158817. PubMed ID: 32980536
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol-dependent increases in glucosylceramide synthase activity in Niemann-Pick disease type C model cells: Abnormal trafficking of endogenously formed ceramide metabolites by inhibition of the enzyme.
Hashimoto N; Matsumoto I; Takahashi H; Ashikawa H; Nakamura H; Murayama T
Neuropharmacology; 2016 Nov; 110(Pt A):458-469. PubMed ID: 27539961
[TBL] [Abstract][Full Text] [Related]
3. Reduced UDP-glucose Levels Are Associated with P-glycoprotein Over-expression in L1210 Cells and Limit Glucosylceramide Synthase Activity.
Turáková K; Pavlíková L; Messingerová L; Lakatoš B; Breier A; Sulová Z
Anticancer Res; 2015 May; 35(5):2627-34. PubMed ID: 25964538
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
Kartal Yandım M; Apohan E; Baran Y
Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
[TBL] [Abstract][Full Text] [Related]
5. Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase.
Gupta V; Patwardhan GA; Zhang QJ; Cabot MC; Jazwinski SM; Liu YY
J Lipid Res; 2010 Apr; 51(4):866-74. PubMed ID: 19826105
[TBL] [Abstract][Full Text] [Related]
6. AMP-activated Protein Kinase Suppresses Biosynthesis of Glucosylceramide by Reducing Intracellular Sugar Nucleotides.
Ishibashi Y; Hirabayashi Y
J Biol Chem; 2015 Jul; 290(29):18245-18260. PubMed ID: 26048992
[TBL] [Abstract][Full Text] [Related]
7. Amyloid Beta-Peptide 25-35 (Aβ
Tang Z; Motoyoshi K; Honda T; Nakamura H; Murayama T
Biol Pharm Bull; 2021; 44(10):1419-1426. PubMed ID: 34602551
[TBL] [Abstract][Full Text] [Related]
8. Complex formation of sphingomyelin synthase 1 with glucosylceramide synthase increases sphingomyelin and decreases glucosylceramide levels.
Hayashi Y; Nemoto-Sasaki Y; Matsumoto N; Hama K; Tanikawa T; Oka S; Saeki T; Kumasaka T; Koizumi T; Arai S; Wada I; Yokoyama K; Sugiura T; Yamashita A
J Biol Chem; 2018 Nov; 293(45):17505-17522. PubMed ID: 30242129
[TBL] [Abstract][Full Text] [Related]
9. Formation of glucosylceramide and sterol glucoside by a UDP-glucose-dependent glucosylceramide synthase from cotton expressed in Pichia pastoris.
Hillig I; Leipelt M; Ott C; Zähringer U; Warnecke D; Heinz E
FEBS Lett; 2003 Oct; 553(3):365-9. PubMed ID: 14572652
[TBL] [Abstract][Full Text] [Related]
10. Glucose availability and glycolytic metabolism dictate glycosphingolipid levels.
Stathem M; Marimuthu S; O'Neal J; Rathmell JC; Chesney JA; Beverly LJ; Siskind LJ
J Cell Biochem; 2015 Jan; 116(1):67-80. PubMed ID: 25145677
[TBL] [Abstract][Full Text] [Related]
11. Regulation of alkaline ceramidase activity by the c-Src-mediated pathway.
Sasaki H; Toyomura K; Matsuzaki W; Okamoto A; Yamaguchi N; Nakamura H; Murayama T
Arch Biochem Biophys; 2014 May; 550-551():12-9. PubMed ID: 24708996
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.
Turzanski J; Grundy M; Shang S; Russell N; Pallis M
Exp Hematol; 2005 Jan; 33(1):62-72. PubMed ID: 15661399
[TBL] [Abstract][Full Text] [Related]
13. Trafficking of Acetyl-C16-Ceramide-NBD with Long-Term Stability and No Cytotoxicity into the Golgi Complex.
Makiyama T; Nakamura H; Nagasaka N; Yamashita H; Honda T; Yamaguchi N; Nishida A; Murayama T
Traffic; 2015 May; 16(5):476-92. PubMed ID: 25615589
[TBL] [Abstract][Full Text] [Related]
14. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells.
Liu YY; Han TY; Giuliano AE; Cabot MC
J Biol Chem; 1999 Jan; 274(2):1140-6. PubMed ID: 9873062
[TBL] [Abstract][Full Text] [Related]
15. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.
Liu YY; Gupta V; Patwardhan GA; Bhinge K; Zhao Y; Bao J; Mehendale H; Cabot MC; Li YT; Jazwinski SM
Mol Cancer; 2010 Jun; 9():145. PubMed ID: 20540746
[TBL] [Abstract][Full Text] [Related]
16. WP1066, a small molecule inhibitor of the JAK/STAT3 pathway, inhibits ceramide glucosyltransferase activity.
Tsurumaki H; Katano H; Sato K; Imai R; Niino S; Hirabayashi Y; Ichikawa S
Biochem Biophys Res Commun; 2017 Sep; 491(2):265-270. PubMed ID: 28739255
[TBL] [Abstract][Full Text] [Related]
17. ABCB1 protects kidney proximal tubule cells against cadmium-induced apoptosis: roles of cadmium and ceramide transport.
Lee WK; Torchalski B; Kohistani N; Thévenod F
Toxicol Sci; 2011 Jun; 121(2):343-56. PubMed ID: 21436125
[TBL] [Abstract][Full Text] [Related]
18. A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer.
Madigan JP; Robey RW; Poprawski JE; Huang H; Clarke CJ; Gottesman MM; Cabot MC; Rosenberg DW
Exp Cell Res; 2020 Mar; 388(2):111860. PubMed ID: 31972222
[TBL] [Abstract][Full Text] [Related]
19. Induction of ceramide glucosyltransferase activity in cultured human keratinocytes. Correlation with culture differentiation.
Sando GN; Howard EJ; Madison KC
J Biol Chem; 1996 Sep; 271(36):22044-51. PubMed ID: 8703011
[TBL] [Abstract][Full Text] [Related]
20. Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide.
Yamaji T; Horie A; Tachida Y; Sakuma C; Suzuki Y; Kushi Y; Hanada K
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
